{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:03:55Z","timestamp":1740114235612,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Tianjin Municipal Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.neulet.2024.138011","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:14:33Z","timestamp":1729142073000},"page":"138011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of plasma neurofilament light chain and Lipoprotein-related phospholipase A2 with motor subtypes of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"843","author":[{"given":"Jinghui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meili","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2024.138011_b0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.neulet.2024.138011_b0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.neulet.2024.138011_b0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","article-title":"The progression of pathology in Parkinson's disease","volume":"1184","author":"Halliday","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neulet.2024.138011_b0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neulet.2024.138011_b0025","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1074\/mcp.R113.032730","article-title":"Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies","volume":"12","author":"Schmid","year":"2013","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/j.neulet.2024.138011_b0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","article-title":"Blood neurofilament light chain in Parkinson's disease","volume":"130","author":"Buhmann","year":"2023","journal-title":"Journal of neural transmission (Vienna Austria: 1996)"},{"key":"10.1016\/j.neulet.2024.138011_b0035","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.2174\/1381612820666140622200916","article-title":"Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A2 (Lp-PLA2) bound to LDL and HDL","volume":"20","author":"Tellis","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.neulet.2024.138011_b0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2024.138011_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.neulet.2024.138011_b0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.neulet.2024.138011_b0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0327(88)90072-9","article-title":"The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders","volume":"14","author":"Maier","year":"1988","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.neulet.2024.138011_b0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","article-title":"Severity classification on the Hamilton Depression Rating Scale","volume":"150","author":"Zimmerman","year":"2013","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.neulet.2024.138011_b0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/jnnp.2006.111161","article-title":"The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine","volume":"78","author":"Hagell","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.neulet.2024.138011_b0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.neulet.2024.138011_b0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.sleep.2023.07.008","article-title":"Epworth sleepiness scale: A meta-analytic study on the internal consistency","volume":"109","author":"Gon\u00e7alves","year":"2023","journal-title":"Sleep Medicine"},{"key":"10.1016\/j.neulet.2024.138011_b0080","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/sleep\/31.11.1601","article-title":"Validation of the fatigue severity scale in a Swiss cohort","volume":"31","author":"Valko","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.neulet.2024.138011_b0085","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2024.138011_b0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neulet.2024.138011_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.06.025","article-title":"Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease","volume":"56","author":"O'Keeffe","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.neulet.2024.138011_b0100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2024.138011_b0105","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL: A biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2024.138011_b0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2021.07.028","article-title":"Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD)","volume":"90","author":"Niemann","year":"2021","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.neulet.2024.138011_b0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-020-00385-5","article-title":"Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease","volume":"15","author":"Ng","year":"2020","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.neulet.2024.138011_b0120","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.neulet.2024.138011_b0125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target","volume":"25","author":"Zalewski","year":"2005","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.neulet.2024.138011_b0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nprot.2006.375","article-title":"Quantification of F2-isoprostanes as a biomarker of oxidative stress","volume":"2","author":"Milne","year":"2007","journal-title":"Nature Protocols"},{"key":"10.1016\/j.neulet.2024.138011_b0150","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2009.11.026","article-title":"Oxidative damage in Parkinson disease: Measurement using accurate biomarkers","volume":"48","author":"Seet","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.neulet.2024.138011_b0155","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/eurheartj\/ehp311","article-title":"Lipoprotein-associated phospholipase A(2), a marker of vascular inflammation and systemic vulnerability","volume":"30","author":"M\u00fcnzel","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1016\/j.neulet.2024.138011_b0160","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.neulet.2024.138011_b0165","first-page":"123","article-title":"PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells, The journal of pathology","volume":"3","author":"Lehtinen","year":"2017","journal-title":"Clinical Research"},{"key":"10.1016\/j.neulet.2024.138011_b0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.prostaglandins.2016.01.001","article-title":"Association between platelet activating factor acetylhydrolase and diabetic retinopathy: Does inflammation affect the retinal status?","volume":"122","author":"Moschos","year":"2016","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.neulet.2024.138011_b0175","doi-asserted-by":"crossref","first-page":"e23068","DOI":"10.1002\/jcla.23068","article-title":"Comparison of serum Lp-PLA2 levels in ischemic stroke patients with H-type hypertension or non-H-type hypertension","volume":"34","author":"Qiao","year":"2020","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"10.1016\/j.neulet.2024.138011_b0180","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.dadm.2015.08.001","article-title":"Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease","volume":"1","author":"Doody","year":"2015","journal-title":"Alzheimer's & Dementia (Amsterdam, Netherlands)"},{"key":"10.1016\/j.neulet.2024.138011_b0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/alzrt154","article-title":"Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study","volume":"4","author":"Davidson","year":"2012","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.neulet.2024.138011_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2016.01.014","article-title":"No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease","volume":"77","author":"Savas","year":"2016","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.neulet.2024.138011_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.633022","article-title":"Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson's Disease","volume":"15","author":"Wu","year":"2021","journal-title":"Frontiers in Neuroscience"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024003902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024003902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T08:13:28Z","timestamp":1732868008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394024003902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"alternative-id":["S0304394024003902"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2024.138011","relation":{},"ISSN":["0304-3940"],"issn-type":[{"type":"print","value":"0304-3940"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of plasma neurofilament light chain and Lipoprotein-related phospholipase A2 with motor subtypes of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2024.138011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"138011"}}